BioWorld MedTech

July 9, 2018

Implandata eyes European launch of intraocular pressure sensor

LONDON – Implandata Ophthalmic Products GmbH is gearing up for the European launch of its Eyemate implantable intraocular pressure sensor, as it nears the second closing of a €8 million (US$9.3 million) series C round. Read More

Quantum raises $50M in series A to develop robotic liver cancer treatment

ICD implant rates study says docs eased up after DoJ action

Mount Sinai researchers discover microRNA activity biomarkers in bladder cancer

Toronto lab develops system to eliminate HCV in donated lungs

Financings

Regulatory front

Product briefs

BioWorld MedTech stock report for public med-tech companies

BioWorld MedTech's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...